GridAI Technologies GRDX
NASDAQ GRDX
$3.57 -0.18 (-4.83%)
As of: Aug 21, 2026 · 3:59 PM EDT

GridAI Technologies (GRDX) Net Income towards Common Stockholders (2015 - 2025)

GridAI Technologies' (GRDX) quarterly Net Income towards Common Stockholders came in at -$3.1 million in Q4 2025, up 75.14% YoY from -$1.8 million in Q4 2024, and down 146.47% on a QoQ basis from -$1.2 million in Q3 2025.

GridAI Technologies (GRDX) Net Income towards Common Stockholders (2015 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has 11 years of Net Income towards Common Stockholders data on file, last reported at -$3.1 million in Q4 2025.

  • Quarterly Net Income towards Common Stockholders rose 75.14% year-over-year to -$3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$6.7 million (up 63.3% YoY) and the FY2025 annual result came in at -$6.7 million, up 63.23% from the prior year.
  • Net Income towards Common Stockholders slipped to -$3.1 million in Q4 2025, from -$1.2 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $5.5 million in Q1 2024 to a low of -$30.5 million in Q3 2021.
  • A 5-year average of -$7.0 million and a median of -$4.1 million in 2023 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2021 — Net Income towards Common Stockholders slumped 469.84% — and 2024, when it soared 235.15%.
  • Tracing GRDX's Net Income towards Common Stockholders over 5 years: stood at -$11.3 million in 2021, then surged by 79.79% to -$2.3 million in 2022, then plunged by 83.15% to -$4.2 million in 2023, then tumbled by 195.08% to -$12.3 million in 2024, then jumped by 75.14% to -$3.1 million in 2025.
  • The last three Net Income towards Common Stockholders figures came in at -$3.1 million (Q4 2025), -$1.2 million (Q3 2025), and -$1.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -174.37 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -13.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 GridAI Technologies 5.82 Mn 5.82 Mn - -3.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.07 Mn
Sep 30, 2025 -1.24 Mn
Jun 30, 2025 -1.08 Mn
Mar 31, 2025 -1.34 Mn
Dec 31, 2024 -12.33 Mn
Sep 30, 2024 -2.67 Mn
Jun 30, 2024 -8.85 Mn
Mar 31, 2024 5.50 Mn
Dec 31, 2023 -4.18 Mn
Sep 30, 2023 -3.48 Mn
Jun 30, 2023 -4.28 Mn
Mar 31, 2023 -4.07 Mn
Dec 31, 2022 -2.28 Mn
Sep 30, 2022 4.05 Mn
Jun 30, 2022 -5.55 Mn
Mar 31, 2022 -10.31 Mn
Dec 31, 2021 -11.29 Mn
Sep 30, 2021 -30.52 Mn
Jun 30, 2021 -12.73 Mn
Mar 31, 2021 -29.98 Mn